HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carol L Shields Selected Research

Cryotherapy (Therapy, Cold)

7/2021Ocular adnexal lymphoma: A single-institution retrospective study.
11/2020Modern treatment of retinoblastoma: A 2020 review.
7/2020Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
1/2019Coats disease: An overview of classification, management and outcomes.
1/2019Intraocular medulloepithelioma - A review of clinical features, DICER 1 mutation, and management.
8/2017RHEGMATOGENOUS RETINAL DETACHMENT AFTER INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: The 2016 Founders Award Lecture.
7/2016Familial Exudative Vitreoretinopathy With a Novel LRP5 Mutation.
7/2015Sebaceous Carcinoma of the Ocular Region: The 2014 Professor Winifred Mao Lecture.
9/2014Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy.
8/2014Cryotherapy-induced release of epiretinal membrane associated with retinal vasoproliferative tumor: analysis of 16 cases.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carol L Shields Research Topics

Disease

224Neoplasms (Cancer)
12/2022 - 02/2002
128Retinoblastoma (Glioblastoma, Retinal)
05/2022 - 04/2002
111Melanoma (Melanoma, Malignant)
04/2022 - 02/2002
64Neoplasm Metastasis (Metastasis)
03/2022 - 07/2002
43Uveal melanoma
01/2022 - 10/2002
29Retinal Detachment (Retinal Detachments)
01/2020 - 07/2002
26Nevus (Nevi)
11/2022 - 08/2002
21Hamartoma
12/2021 - 05/2003
18Macular Edema
10/2020 - 11/2004
18Atrophy
12/2019 - 03/2008
14Macular Degeneration (Age-Related Maculopathy)
05/2021 - 07/2002
13Vitreous Hemorrhage
03/2021 - 07/2002
13Cataract (Cataracts)
01/2019 - 07/2002
13Edema (Dropsy)
10/2017 - 04/2005
12Glaucoma
04/2022 - 08/2002
12Lymphoma (Lymphomas)
01/2022 - 02/2011
12Retinal Neoplasms
01/2020 - 04/2002
12Hemorrhage
01/2020 - 03/2009
11Papilledema
10/2020 - 09/2004
10Retinal Telangiectasis
10/2020 - 11/2004
10Astrocytoma (Pilocytic Astrocytoma)
10/2020 - 01/2004
9Hemangioblastoma
01/2022 - 01/2008
9Ischemia
01/2021 - 06/2002
9Hemangioma (Angioma)
10/2020 - 05/2005
9Monosomy
01/2018 - 01/2007
8Osteoma
10/2020 - 12/2007
8Neovascular Glaucoma
06/2016 - 07/2002
7Fibrosis (Cirrhosis)
01/2017 - 09/2008
7Epiretinal Membrane (Epiretinal Membranes)
08/2015 - 03/2008
6Necrosis
11/2021 - 04/2012
6Capillary Hemangioma
10/2020 - 03/2002
6Tuberous Sclerosis (Bourneville's Disease)
01/2020 - 01/2004
6Carcinoma (Carcinomatosis)
01/2020 - 11/2002
6Choroidal Neovascularization
01/2019 - 01/2008
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2016 - 05/2002
5Hypertrophy
05/2021 - 06/2005
5Telangiectasis (Telangiectasia)
10/2020 - 03/2012
5Cicatrix (Scar)
05/2020 - 05/2014
5Breast Neoplasms (Breast Cancer)
07/2019 - 06/2006
5Hyperplasia
12/2017 - 04/2002
5Cysts
05/2015 - 01/2005
5Inflammation (Inflammations)
06/2014 - 03/2002
4Lung Neoplasms (Lung Cancer)
03/2022 - 05/2014
4Pain (Aches)
01/2022 - 02/2003
4Primitive Neuroectodermal Tumors (PNET)
01/2021 - 08/2011
4Hypertension (High Blood Pressure)
01/2020 - 05/2010
4Familial Exudative Vitreoretinopathies
12/2019 - 02/2012
3Rupture
11/2021 - 05/2010
3Metaplasia
11/2021 - 02/2010
3Retinoschisis (Retinoschisis, Juvenile)
10/2020 - 06/2005
3photopsia
10/2020 - 12/2018

Drug/Important Bio-Agent (IBA)

121Retinaldehyde (Retinal)IBA
12/2022 - 03/2002
31Fluorescein (Funduscein)FDA LinkGeneric
12/2022 - 06/2003
29Retinal Pigments (Pigments, Visual)IBA
11/2022 - 12/2005
21Melphalan (Alkeran)FDA LinkGeneric
03/2021 - 06/2011
17Bevacizumab (Avastin)FDA Link
03/2022 - 01/2008
17Dihydrotachysterol (AT 10)IBA
12/2020 - 10/2002
15Carboplatin (JM8)FDA LinkGeneric
01/2020 - 04/2002
15Vincristine (Oncovin)FDA LinkGeneric
01/2020 - 04/2002
13Etoposide (VP 16)FDA LinkGeneric
01/2020 - 04/2002
12Iodine-125IBA
05/2022 - 03/2003
121-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2022 - 09/2004
12IodineIBA
12/2018 - 10/2002
11LipofuscinIBA
03/2021 - 10/2007
8Coloring Agents (Dyes)IBA
10/2022 - 03/2008
7Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2022 - 06/2003
7Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2013
7Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 03/2002
7Pharmaceutical PreparationsIBA
04/2019 - 05/2011
6InterferonsIBA
11/2021 - 07/2011
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 01/2008
5Topotecan (Hycamtin)FDA LinkGeneric
11/2018 - 08/2014
4Biological ProductsIBA
11/2022 - 11/2005
4Capsules (Microcapsules)IBA
03/2022 - 01/2011
4Protons (Proton)IBA
10/2021 - 03/2015
4MART-1 AntigenIBA
09/2021 - 04/2018
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2007
4Keratins (Keratin)IBA
01/2021 - 05/2005
4Immune Checkpoint InhibitorsIBA
01/2020 - 11/2017
4Verteporfin (Visudyne)FDA Link
01/2020 - 05/2005
4Triamcinolone (Aristocort)FDA Link
09/2012 - 07/2008
4Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
02/2011 - 10/2005
4Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2005 - 02/2002

Therapy/Procedure

137Radiotherapy
05/2022 - 02/2002
100Drug Therapy (Chemotherapy)
05/2022 - 06/2002
73Therapeutics
03/2022 - 04/2002
38Induced Hyperthermia (Thermotherapy)
10/2021 - 02/2002
33Cryotherapy (Therapy, Cold)
07/2021 - 04/2002
22Traction
03/2019 - 02/2004
21Photochemotherapy (Photodynamic Therapy)
01/2022 - 06/2003
21Lasers (Laser)
11/2020 - 08/2002
16Aftercare (After-Treatment)
10/2020 - 02/2002
16Light Coagulation
01/2019 - 10/2002
14Brachytherapy
10/2021 - 08/2002
13Injections
03/2022 - 09/2008
6Conservative Treatment
01/2019 - 12/2002
6Vitrectomy
09/2013 - 09/2007
4Iridectomy
04/2018 - 03/2005
4Immunotherapy
02/2015 - 07/2006
3Salvage Therapy
01/2022 - 11/2006